Cargando…
Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model
BACKGROUND: Inducible costimulator (ICOS) is rapidly upregulated with T-cell stimulation and may represent an escape pathway for T-cell costimulation in the setting of CD40/CD154 costimulation blockade. Induction treatment exhibited no efficacy in a primate renal allograft model, but rodent transpla...
Autores principales: | O’Neill, Natalie A., Zhang, Tianshu, Braileanu, Gheorghe, Cheng, Xiangfei, Hershfeld, Alena, Sun, Wenji, Reimann, Keith A., Dahi, Sia, Kubicki, Natalia, Hassanein, Wessam, Laird, Christopher, Cimeno, Arielle, Azimzadeh, Agnes M., Pierson, Richard N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811273/ https://www.ncbi.nlm.nih.gov/pubmed/29464205 http://dx.doi.org/10.1097/TXD.0000000000000761 |
Ejemplares similares
-
ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020) -
Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989) -
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020) -
Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021) -
ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)